REGENERON PHARMACEUTICALS, INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
REGENERON PHARMACEUTICALS, INC. (REGN) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $600.40 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-07-30
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was $492.70M, a 127.68% increase year-over-year.
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was $107.70M.
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was -$24.70M, a 110.95% decline year-over-year.
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $759.20M, a 290.53% increase year-over-year.
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $736.80M, a 0.23% increase from fiscal 2024.
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $735.10M, a 22.80% increase from fiscal 2023.
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $598.60M.
- REGENERON PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was -$138.40M, a 115.98% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $492.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $600.40M 10-Q · filed 2026-07-30 | $575.70M derived: sum of 3 quarters · filed 2026-07-30 | $1.33B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | $107.70M 10-Q · filed 2026-04-29 | $83.00M derived: sum of 2 quarters · filed 2026-04-29 | $842.20M derived: sum of 3 quarters · filed 2026-04-29 | $1.06B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | -$24.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $734.50M derived: sum of 2 quarters · filed 2026-02-04 | $950.90M derived: sum of 3 quarters · filed 2026-07-30 | $736.80M 10-K · filed 2026-02-04 | ||||
| 2025-09-30 | $759.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $975.60M derived: sum of 2 quarters · filed 2026-07-30 | $761.50M 10-Q · filed 2025-10-28 | $987.10M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $216.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $2.30M 10-Q · filed 2026-07-30 | $227.90M derived: sum of 3 quarters · filed 2026-07-30 | $422.30M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | -$214.10M 10-Q · filed 2026-04-29 | $11.50M derived: sum of 2 quarters · filed 2026-04-29 | $205.90M derived: sum of 3 quarters · filed 2026-04-29 | $410.50M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2024-12-31 | $225.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $420.00M derived: sum of 2 quarters · filed 2026-02-04 | $624.60M derived: sum of 3 quarters · filed 2026-02-04 | $735.10M 10-K · filed 2026-02-04 | ||||
| 2024-09-30 | $194.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $399.00M derived: sum of 2 quarters · filed 2025-10-28 | $509.50M 10-Q · filed 2025-10-28 | $370.80M derived: sum of 4 quarters · filed 2026-02-04 | ||||
| 2024-06-30 | $204.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $315.10M 10-Q · filed 2025-08-01 | $176.40M derived: sum of 3 quarters · filed 2026-02-04 | $755.00M derived: sum of 4 quarters · filed 2026-02-04 | ||||
| 2024-03-31 | $110.50M 10-Q · filed 2025-04-29 | -$28.20M derived: sum of 2 quarters · filed 2026-02-04 | $550.40M derived: sum of 3 quarters · filed 2026-02-04 | $590.10M derived: sum of 4 quarters · filed 2026-02-04 | ||||
| 2023-12-31 | -$138.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $439.90M derived: sum of 2 quarters · filed 2026-02-04 | $479.60M derived: sum of 3 quarters · filed 2026-02-04 | $598.60M 10-K · filed 2026-02-04 | ||||
| 2023-09-30 | $578.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $618.30M derived: sum of 2 quarters · filed 2024-10-31 | $737.30M 10-Q · filed 2024-10-31 | $1.08B derived: sum of 4 quarters · filed 2025-02-05 | ||||
| 2023-06-30 | $39.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $158.70M 10-Q · filed 2024-08-01 | $506.30M derived: sum of 3 quarters · filed 2025-02-05 | $346.00M derived: sum of 4 quarters · filed 2025-02-05 | ||||
| 2023-03-31 | $119.00M 10-Q · filed 2024-05-02 | $466.60M derived: sum of 2 quarters · filed 2025-02-05 | $306.30M derived: sum of 3 quarters · filed 2025-02-05 | $231.00M derived: sum of 4 quarters · filed 2025-02-05 | ||||
| 2022-12-31 | $347.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-05 | $187.30M derived: sum of 2 quarters · filed 2025-02-05 | $112.00M derived: sum of 3 quarters · filed 2025-02-05 | -$138.40M 10-K · filed 2025-02-05 | ||||
| 2022-09-30 | -$160.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$235.60M derived: sum of 2 quarters · filed 2023-11-02 | -$486.00M 10-Q · filed 2023-11-02 | -$120.30M derived: sum of 4 quarters · filed 2024-02-05 | ||||
| 2022-06-30 | -$75.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$325.70M 10-Q · filed 2023-08-03 | $40.00M derived: sum of 3 quarters · filed 2024-02-05 | $116.70M derived: sum of 4 quarters · filed 2024-02-05 | ||||
| 2022-03-31 | -$250.40M 10-Q · filed 2023-05-04 | $115.30M derived: sum of 2 quarters · filed 2024-02-05 | $192.00M derived: sum of 3 quarters · filed 2024-02-05 | $650.40M derived: sum of 4 quarters · filed 2024-02-05 | ||||
| 2021-12-31 | $365.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-05 | $442.40M derived: sum of 2 quarters · filed 2024-02-05 | $900.80M derived: sum of 3 quarters · filed 2024-02-05 | $866.10M 10-K · filed 2024-02-05 | ||||
| 2021-09-30 | $76.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $535.10M derived: sum of 2 quarters · filed 2022-11-03 | $500.40M 10-Q · filed 2022-11-03 | $538.50M derived: sum of 4 quarters · filed 2023-02-06 | ||||
| 2021-06-30 | $458.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $423.70M 10-Q · filed 2022-08-03 | $461.80M derived: sum of 3 quarters · filed 2023-02-06 | $521.70M derived: sum of 4 quarters · filed 2023-02-06 | ||||
| 2021-03-31 | -$34.70M 10-Q · filed 2022-05-04 | $3.40M derived: sum of 2 quarters · filed 2023-02-06 | $63.30M derived: sum of 3 quarters · filed 2023-02-06 | $169.40M derived: sum of 4 quarters · filed 2023-02-06 | ||||
| 2020-12-31 | $38.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-06 | $98.00M derived: sum of 2 quarters · filed 2023-02-06 | $204.10M derived: sum of 3 quarters · filed 2023-02-06 | $118.90M 10-K · filed 2023-02-06 | ||||
| 2020-09-30 | $59.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $166.00M derived: sum of 2 quarters · filed 2021-11-04 | $80.80M 10-Q · filed 2021-11-04 | $350.90M derived: sum of 4 quarters · filed 2022-02-07 | ||||
| 2020-06-30 | $106.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $20.90M 10-Q · filed 2021-08-05 | $291.00M derived: sum of 3 quarters · filed 2022-02-07 | $238.30M derived: sum of 4 quarters · filed 2022-02-07 | ||||
| 2020-03-31 | -$85.20M 10-Q · filed 2021-05-06 | $184.90M derived: sum of 2 quarters · filed 2022-02-07 | $132.20M derived: sum of 3 quarters · filed 2022-02-07 | $188.00M derived: sum of 4 quarters · filed 2022-02-07 | ||||
| 2019-12-31 | $270.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-07 | $217.40M derived: sum of 2 quarters · filed 2022-02-07 | $273.20M derived: sum of 3 quarters · filed 2022-02-07 | $599.00M 10-K · filed 2022-02-07 | $444.50M 10-K · filed 2020-02-07 | |||
| 2019-09-30 | -$52.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $3.10M derived: sum of 2 quarters · filed 2020-11-05 | $328.90M 10-Q · filed 2020-11-05 | $119.90M 10-Q · filed 2019-11-05 | $207.80M derived: sum of 4 quarters · filed 2021-02-08 | |||
| 2019-06-30 | $55.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $381.60M 10-Q · filed 2020-08-05 | $110.30M 10-Q · filed 2019-08-06 | $260.50M derived: sum of 3 quarters · filed 2021-02-08 | $373.40M derived: sum of 4 quarters · filed 2021-02-08 | |||
| 2019-03-31 | $325.80M 10-Q · filed 2020-05-05 | -$19.60M 10-Q · filed 2019-05-07 | $204.70M derived: sum of 2 quarters · filed 2021-02-08 | $317.60M derived: sum of 3 quarters · filed 2021-02-08 | $307.90M derived: sum of 4 quarters · filed 2021-02-08 | |||
| 2018-12-31 | -$121.10M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-08 | -$8.20M derived: sum of 2 quarters · filed 2021-02-08 | -$17.90M derived: sum of 3 quarters · filed 2021-02-08 | $58.80M 10-K · filed 2021-02-08 | $210.00M 10-K · filed 2019-02-07 | |||
| 2018-09-30 | $112.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $103.20M derived: sum of 2 quarters · filed 2019-11-05 | $179.90M 10-Q · filed 2019-11-05 | $179.85M 10-Q · filed 2018-11-06 | $185.61M derived: sum of 4 quarters · filed 2020-02-07 | |||
| 2018-06-30 | -$9.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $67.00M 10-Q · filed 2019-08-06 | $66.98M 10-Q · filed 2018-08-02 | $72.71M derived: sum of 3 quarters · filed 2020-02-07 | $191.03M derived: sum of 4 quarters · filed 2020-02-07 | |||
| 2018-03-31 | $76.70M 10-Q · filed 2019-05-07 | $76.65M 10-Q · filed 2018-05-03 | $82.41M derived: sum of 2 quarters · filed 2020-02-07 | $200.73M derived: sum of 3 quarters · filed 2020-02-07 | -$134.19M derived: sum of 4 quarters · filed 2020-02-07 | |||
| 2017-12-31 | $5.71M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-07 | $124.03M derived: sum of 2 quarters · filed 2020-02-07 | -$210.90M derived: sum of 3 quarters · filed 2020-02-07 | -$23.20M 10-K · filed 2020-02-07 | -$23.19M 10-K · filed 2018-02-08 | |||
| 2017-09-30 | $118.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$216.60M derived: sum of 2 quarters · filed 2018-11-06 | -$28.91M 10-Q · filed 2018-11-06 | $117.65M derived: sum of 4 quarters · filed 2019-02-07 | ||||
| 2017-06-30 | -$334.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | -$147.23M 10-Q · filed 2018-08-02 | -$670.00K derived: sum of 3 quarters · filed 2019-02-07 | -$27.16M derived: sum of 4 quarters · filed 2019-02-07 | ||||
| 2017-03-31 | $187.69M 10-Q · filed 2018-05-03 | $334.26M derived: sum of 2 quarters · filed 2019-02-07 | $307.77M derived: sum of 3 quarters · filed 2019-02-07 | $338.26M derived: sum of 4 quarters · filed 2019-02-07 | ||||
| 2016-12-31 | $146.56M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-07 | $120.08M derived: sum of 2 quarters · filed 2019-02-07 | $150.57M derived: sum of 3 quarters · filed 2019-02-07 | $254.00M 10-K · filed 2019-02-07 | $253.98M 10-K · filed 2017-02-09 | |||
| 2016-09-30 | -$26.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $4.01M derived: sum of 2 quarters · filed 2017-11-08 | $107.44M 10-Q · filed 2017-11-08 | $246.44M derived: sum of 4 quarters · filed 2018-02-08 | ||||
| 2016-06-30 | $30.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $133.93M 10-Q · filed 2017-08-03 | $272.93M derived: sum of 3 quarters · filed 2018-02-08 | $308.24M derived: sum of 4 quarters · filed 2018-02-08 | ||||
| 2016-03-31 | $103.43M 10-Q · filed 2017-05-04 | $242.44M derived: sum of 2 quarters · filed 2018-02-08 | $277.75M derived: sum of 3 quarters · filed 2018-02-08 | $376.97M derived: sum of 4 quarters · filed 2018-02-08 | ||||
| 2015-12-31 | $139.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-08 | $174.32M derived: sum of 2 quarters · filed 2018-02-08 | $273.54M derived: sum of 3 quarters · filed 2018-02-08 | $303.66M 10-K · filed 2018-02-08 | ||||
| 2015-09-30 | $35.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $134.53M derived: sum of 2 quarters · filed 2016-11-04 | $164.65M 10-Q · filed 2016-11-04 | $249.33M derived: sum of 4 quarters · filed 2017-02-09 | ||||
| 2015-06-30 | $99.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $129.34M 10-Q · filed 2016-08-04 | $214.01M derived: sum of 3 quarters · filed 2017-02-09 | $273.70M derived: sum of 4 quarters · filed 2017-02-09 | ||||
| 2015-03-31 | $30.12M 10-Q · filed 2016-05-05 | $25.53M 10-Q · filed 2015-05-07 | $114.79M derived: sum of 2 quarters · filed 2017-02-09 | $174.48M derived: sum of 3 quarters · filed 2017-02-09 | $205.44M derived: sum of 4 quarters · filed 2017-02-09 | |||
| 2014-12-31 | $84.68M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-09 | $144.36M derived: sum of 2 quarters · filed 2017-02-09 | $175.32M derived: sum of 3 quarters · filed 2017-02-09 | $161.18M 10-K · filed 2017-02-09 | $162.24M 10-K · filed 2015-02-12 | |||
| 2014-09-30 | $59.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $90.64M derived: sum of 2 quarters · filed 2015-11-04 | $76.51M 10-Q · filed 2015-11-04 | $118.30M derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2014-06-30 | $30.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $16.82M 10-Q · filed 2015-08-04 | $58.61M derived: sum of 3 quarters · filed 2016-02-11 | $117.91M derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2014-03-31 | -$14.14M 10-Q · filed 2015-05-07 | $27.65M derived: sum of 2 quarters · filed 2016-02-11 | $86.95M derived: sum of 3 quarters · filed 2016-02-11 | $90.44M derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2013-12-31 | $41.79M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | $101.09M derived: sum of 2 quarters · filed 2016-02-11 | $104.58M derived: sum of 3 quarters · filed 2016-02-11 | $136.68M 10-K · filed 2016-02-11 | ||||
| 2013-09-30 | $59.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $62.79M derived: sum of 2 quarters · filed 2014-11-04 | $94.89M 10-Q · filed 2014-11-04 | $76.64M derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2013-06-30 | $3.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $35.59M 10-Q · filed 2014-08-05 | $17.34M derived: sum of 3 quarters · filed 2015-02-12 | $13.78M derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2013-03-31 | $32.10M 10-Q · filed 2014-05-08 | $13.85M derived: sum of 2 quarters · filed 2015-02-12 | $10.29M derived: sum of 3 quarters · filed 2015-02-12 | $30.37M derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2012-12-31 | -$18.25M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12 | -$21.81M derived: sum of 2 quarters · filed 2015-02-12 | -$1.73M derived: sum of 3 quarters · filed 2015-02-12 | $10.98M 10-K · filed 2015-02-12 | ||||
| 2012-09-30 | -$3.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $16.52M derived: sum of 2 quarters · filed 2013-11-05 | $29.23M 10-Q · filed 2013-11-05 | $43.99M derived: sum of 4 quarters · filed 2014-02-13 | ||||
| 2012-06-30 | $20.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $32.79M 10-Q · filed 2013-08-06 | $47.55M derived: sum of 3 quarters · filed 2014-02-13 | $44.23M derived: sum of 4 quarters · filed 2014-02-13 | ||||
| 2012-03-31 | $12.71M 10-Q · filed 2013-05-03 | $27.47M derived: sum of 2 quarters · filed 2014-02-13 | $24.15M derived: sum of 3 quarters · filed 2014-02-13 | $49.15M derived: sum of 4 quarters · filed 2014-02-13 | ||||
| 2011-12-31 | $14.76M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-13 | $11.44M derived: sum of 2 quarters · filed 2014-02-13 | $36.44M derived: sum of 3 quarters · filed 2014-02-13 | $50.02M 10-K · filed 2014-02-13 | ||||
| 2011-09-30 | -$3.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-24 | $21.68M derived: sum of 2 quarters · filed 2012-10-24 | $35.25M 10-Q · filed 2012-10-24 | $14.86M derived: sum of 4 quarters · filed 2013-02-15 | ||||
| 2011-06-30 | $25.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-25 | $38.58M 10-Q · filed 2012-07-25 | $18.18M derived: sum of 3 quarters · filed 2013-02-15 | $28.08M derived: sum of 4 quarters · filed 2013-02-15 | ||||
| 2011-03-31 | $13.57M 10-Q · filed 2012-04-26 | -$6.82M derived: sum of 2 quarters · filed 2013-02-15 | $3.07M derived: sum of 3 quarters · filed 2013-02-15 | $8.54M derived: sum of 4 quarters · filed 2013-02-15 | ||||
| 2010-12-31 | -$20.39M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15 | -$10.50M derived: sum of 2 quarters · filed 2013-02-15 | -$5.04M derived: sum of 3 quarters · filed 2013-02-15 | $7.61M 10-K · filed 2013-02-15 | ||||
| 2010-09-30 | $9.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | $15.36M derived: sum of 2 quarters · filed 2011-10-27 | $28.00M 10-Q · filed 2011-10-27 | $28.35M 10-Q · filed 2010-10-28 | $22.61M derived: sum of 4 quarters · filed 2012-02-21 | |||
| 2010-06-30 | $5.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | $18.11M 10-Q · filed 2011-07-28 | $12.72M derived: sum of 3 quarters · filed 2012-02-21 | $17.64M derived: sum of 4 quarters · filed 2012-02-21 | ||||
| 2010-03-31 | $12.64M 10-Q · filed 2011-05-03 | $7.26M derived: sum of 2 quarters · filed 2012-02-21 | $12.18M derived: sum of 3 quarters · filed 2012-02-21 | |||||
| 2009-12-31 | -$5.38M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-21 | -$468.00K derived: sum of 2 quarters · filed 2012-02-21 | $12.58M 10-K · filed 2012-02-21 | |||||
| 2009-09-30 | $4.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-28 | $17.96M 10-Q · filed 2010-10-28 | ||||||
| 2009-06-30 | $13.04M 10-Q · filed 2010-07-28 | |||||||
| 2008-12-31 | -$5.73M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |